DefiniGEN Joins EBiSC Consortium
DefiniGEN (an investment in the University of Cambridge Enterprise Funds I & II), a leading provider of stem cell life science products and services has joined the European Bank for induced pluripotent stem cells (EBiSC) consortium. The consortium… Read More
Cambridge Enterprise
A huge thank you to all the team at Cambridge Enterprise for an excellent University of Cambridge Enterprise Fund investor evening yesterday at Emmanuel College. Investee companies presenting included: Aqdot (highlighted in the FT yesterday) Cambridge CMOS Sensors DefiniGEN… Read More
